GlassScriptPhysician profile
John M Biltz
NPI 1225001860
$2,764.45
in general payments reported to CMS, 2019-2025
22 companies · $297 in 2025
The $297 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $360 · 2020: $374 · 2021: $501 · 2022: $505 · 2023: $292 · 2024: $434 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $916 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $916.05 |
| Education | $107.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $659.96 | 2019-2025 | Skyrizi |
| Pfizer INC. | $592.93 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $294.59 | 2020-2025 | Dupixent |
| Janssen Biotech, INC. | $283.87 | 2021-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $204.83 | 2019-2025 | Ilumya |
| Genzyme Corporation | $118.11 | 2021-2025 | |
| Allergan, INC. | $113.12 | 2020 | |
| Galderma Laboratories, L.P. | $66.00 | 2021-2023 | |
| Lilly USA, LLC | $57.09 | 2019-2021 | |
| Amgen INC. | $56.56 | 2022-2024 | Otezla |
| E.R. Squibb & Sons, L.L.C. | $50.04 | 2023 | Sotyktu |
| Ucb, INC. | $41.23 | 2021 | |
| Janssen Scientific Affairs, LLC | $39.61 | 2022 | |
| Dusa Pharmaceuticals, INC. | $34.46 | 2019 | |
| Incyte Corporation | $28.82 | 2024 | Opzelura |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $28.27 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $25.31 | 2019-2021 | |
| Verrica Pharmaceuticals INC. | $15.12 | 2025 | Ycanth |
| Smith+Nephew, INC. | $14.36 | 2024 | Grafix Pl |
| Sanofi-Aventis U.S. LLC | $13.61 | 2020 | |
| Sandoz INC. | $13.48 | 2020 | |
| Vyne Pharmaceuticals INC. | $13.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Biltz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.